BCDA
Price
$1.43
Change
+$0.02 (+1.42%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
14.96M
RNAC
Price
$9.23
Change
-$0.23 (-2.43%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
240.78M
Interact to see
Advertisement

BCDA vs RNAC

Header iconBCDA vs RNAC Comparison
Open Charts BCDA vs RNACBanner chart's image
BioCardia
Price$1.43
Change+$0.02 (+1.42%)
Volume$4.39K
Capitalization14.96M
Cartesian Therapeutics
Price$9.23
Change-$0.23 (-2.43%)
Volume$2.06K
Capitalization240.78M
BCDA vs RNAC Comparison Chart in %
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCDA vs. RNAC commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a Buy and RNAC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BCDA: $1.43 vs. RNAC: $9.23)
Brand notoriety: BCDA and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 14% vs. RNAC: 83%
Market capitalization -- BCDA: $14.96M vs. RNAC: $240.78M
BCDA [@Biotechnology] is valued at $14.96M. RNAC’s [@Biotechnology] market capitalization is $240.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 5 TA indicator(s) are bullish while RNAC’s TA Score has 4 bullish TA indicator(s).

  • BCDA’s TA Score: 5 bullish, 5 bearish.
  • RNAC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than BCDA.

Price Growth

BCDA (@Biotechnology) experienced а +23.28% price change this week, while RNAC (@Biotechnology) price change was -2.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($241M) has a higher market cap than BCDA($15M). BCDA YTD gains are higher at: -35.321 vs. RNAC (-48.465). BCDA has higher annual earnings (EBITDA): -8.81M vs. RNAC (-118.73M). RNAC has more cash in the bank: 160M vs. BCDA (980K). BCDA has less debt than RNAC: BCDA (745K) vs RNAC (13.3M). RNAC has higher revenues than BCDA: RNAC (1.03M) vs BCDA (0).
BCDARNACBCDA / RNAC
Capitalization15M241M6%
EBITDA-8.81M-118.73M7%
Gain YTD-35.321-48.46573%
P/E RatioN/A1.98-
Revenue01.03M-
Total Cash980K160M1%
Total Debt745K13.3M6%
FUNDAMENTALS RATINGS
BCDA vs RNAC: Fundamental Ratings
BCDA
RNAC
OUTLOOK RATING
1..100
502
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9488
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (88) in the null industry is in the same range as RNAC (100) in the Biotechnology industry. This means that BCDA’s stock grew similarly to RNAC’s over the last 12 months.

BCDA's Profit vs Risk Rating (100) in the null industry is in the same range as RNAC (100) in the Biotechnology industry. This means that BCDA’s stock grew similarly to RNAC’s over the last 12 months.

BCDA's SMR Rating (100) in the null industry is in the same range as RNAC (100) in the Biotechnology industry. This means that BCDA’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's Price Growth Rating (88) in the Biotechnology industry is in the same range as BCDA (94) in the null industry. This means that RNAC’s stock grew similarly to BCDA’s over the last 12 months.

RNAC's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for BCDA (100) in the null industry. This means that RNAC’s stock grew somewhat faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDARNAC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BCDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPGP79.280.04
+0.05%
IPG Photonics Corp
STM28.30-0.72
-2.48%
STMicroelectronics NV
ORKT0.61-0.02
-3.54%
Orangekloud Technology Inc
PROF5.12-0.25
-4.66%
Profound Medical Corp
IOVA2.02-0.10
-4.72%
Iovance Biotherapeutics

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with RNAC. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
-4.73%
RNAC - BCDA
85%
Closely correlated
-6.06%
CDTX - BCDA
85%
Closely correlated
-4.31%
AGEN - BCDA
85%
Closely correlated
-8.67%
NBY - BCDA
84%
Closely correlated
-0.93%
TAOX - BCDA
84%
Closely correlated
-8.22%
More